Literature DB >> 11214745

Sleep-Disordered breathing in patients referred for angina evaluation--association with left ventricular dysfunction.

B M Sanner1, M Konermann, C Doberauer, T Weiss, W Zidek.   

Abstract

BACKGROUND: Clinical observations have linked sleep-disordered breathing to cardiovascular morbidity and mortality, and especially to coronary artery disease. HYPOTHESIS: The study was undertaken to determine the prevalence of sleep-disordered breathing in consecutive patients referred for angina evaluation, and analyzed the parameters influencing the severity of sleep-disordered breathing.
METHODS: In all, 68 consecutive patients (53 men, 15 women, aged 63.4 +/- 10.0 years) referred for angina evaluation were studied. Coronary angiography, selective left ventriculography, and a polygraphic study with a validated six-channel monitoring device were performed. Full-night polysomnography was used to reevaluate patients with an apnea/hypopnea index > or = 10/h.
RESULTS: Sleep-disordered breathing as defined by an apnea/hypopnea index > or = 10/h was found in 30.9% of patients; its prevalence was not increased in patients with and without coronary artery disease (26.5 vs. 42.1%). Multiple stepwise linear regression analysis revealed that the severity of sleep-disordered breathing was significantly and independently associated with left ventricular ejection fraction (r = -0.38; p = 0.002), but not with age, body mass index, gender, diabetes mellitus, hypertension, hyperuricemia, hypercholesterolemia, smoking habits, or coronary artery disease. In this group of patients, multiple logistic regression analysis could not demonstrate sleep-disordered breathing to be an independent predictor of coronary artery disease.
CONCLUSIONS: Sleep-disordered breathing is common in patients referred for angina evaluation. The degree of sleep-disordered breathing is mainly determined by the extent of left ventricular dysfunction.

Entities:  

Mesh:

Year:  2001        PMID: 11214745      PMCID: PMC6654824          DOI: 10.1002/clc.4960240209

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  4 in total

Review 1.  Cardiovascular disease risk reduction with sleep apnea treatment.

Authors:  Girardin Jean-Louis; Clinton D Brown; Ferdinand Zizi; Gbenga Ogedegbe; Carla Boutin-Foster; Joseph Gorga; Samy I McFarlane
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-07

Review 2.  Adding Insult to Injury: Sleep Deficiency in Hospitalized Patients.

Authors:  Wissam Mansour; Melissa Knauert
Journal:  Clin Chest Med       Date:  2022-06       Impact factor: 4.967

3.  Obstructive sleep apnea and coronary artery disease: from pathophysiology to clinical implications.

Authors:  Fernando De Torres-Alba; Daniele Gemma; Eduardo Armada-Romero; Juan Ramón Rey-Blas; Esteban López-de-Sá; José Luis López-Sendon
Journal:  Pulm Med       Date:  2013-04-15

4.  Prevalence of obstructive sleep apnea among patients with coronary artery disease in Saudi Arabia.

Authors:  Siraj O Wali; Muath A Alsharif; Mohammed H Albanji; Murad S Baabbad; Haneen M Almotary; Nabil Alama; Layth Mimish; Adil Alsulami; Muntasir M Abdelaziz
Journal:  J Saudi Heart Assoc       Date:  2015-03-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.